Literature DB >> 12643360

Alopecia in women.

C Carolyn Thiedke1.   

Abstract

Alopecia can be divided into disorders in which the hair follicle is normal but the cycling of hair growth is abnormal and disorders in which the hair follicle is damaged. Androgenetic alopecia is the most common cause of hair loss in women. Other disorders include alopecia areata, telogen effluvium, cicatricial alopecia, and traumatic alopecias. The diagnosis is usually based on a thorough history and a focused physical examination. In some patients, selected laboratory tests or punch biopsy may be necessary. Topically administered minoxidil is labeled for the treatment of androgenetic alopecia in women. Corticosteroids and other agents are typically used in women with alopecia areata. Telogen effluvium is often a self-limited disorder. Because alopecia can be devastating to women, management should include an assessment for psychologic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643360

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  11 in total

1.  Case studies in anticoagulation management.

Authors:  Wendy A Leong
Journal:  J Thromb Thrombolysis       Date:  2007-10-01       Impact factor: 2.300

2.  Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Product in Healthy Adult Male and Female Volunteers with Hair Fall.

Authors:  Muhammed Majeed; Shaheen Majeed; Kalyanam Nagabhushanam; Lakshmi Mundkur; Prakriti Neupane; Kalpesh Shah
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-09-24

3.  A Randomized, Double-blind, Placebo-controlled, Multi-center, Extension Trial Evaluating the Efficacy of a New Oral Supplement in Women with Self-perceived Thinning Hair.

Authors:  Glynis Ablon; Steven Dayan
Journal:  J Clin Aesthet Dermatol       Date:  2015-12

4.  A Double-blind, Placebo-controlled Study Evaluating the Efficacy of an Oral Supplement in Women with Self-perceived Thinning Hair.

Authors:  Ablon Glynis
Journal:  J Clin Aesthet Dermatol       Date:  2012-11

5.  Bariatric Surgery-Induced Telogen Effluvium (Bar SITE): Case Report and a Review of Hair Loss Following Weight Loss Surgery.

Authors:  Rena A Cohen-Kurzrock; Philip R Cohen
Journal:  Cureus       Date:  2021-04-21

6.  A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair.

Authors:  Glynis Ablon
Journal:  Dermatol Res Pract       Date:  2015-03-25

7.  Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia.

Authors:  Izabela Urysiak-Czubatka; Małgorzata L Kmieć; Grażyna Broniarczyk-Dyła
Journal:  Postepy Dermatol Alergol       Date:  2014-09-08       Impact factor: 1.837

8.  A Practical Guide to Managing Patients With Systemic Symptoms and Breast Implants.

Authors:  Patricia McGuire; Daniel J Clauw; Jason Hammer; Melinda Haws; William P Adams
Journal:  Aesthet Surg J       Date:  2022-03-15       Impact factor: 4.283

Review 9.  Alopecia in anticoagulated patients.

Authors:  Marcos Arêas Marques; Carmen Lucia Lascasas Porto; Ana Letícia de Matos Milhomens; Juliana de Miranda Vieira; Claudia Carvalho Alcântara Gomes; Ana Thereza Cavalcanti Rocha; Cíntia da Silva Miller
Journal:  J Vasc Bras       Date:  2020-06-08

10.  Agent specific effects of anticoagulant induced alopecia.

Authors:  Angela C Weyand; Jordan A Shavit
Journal:  Res Pract Thromb Haemost       Date:  2017-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.